News
Mzukisi Ndamase, who is currently serving a life sentence for murder, is accused of orchestrating the massacre while behind ...
18m
RSVP Live on MSNMost common painkiller in the world may cause 'risky behaviour'Paracetamol, known as Acetaminophen in the US, is one of the most widely used drugs in the world and scientists are now ...
People with obesity who took Eli Lilly's daily oral GLP-1 drug orforglipron lost an average of 12.4% of their body weight, ...
Dailymotion on MSN26m
NationalWorld Celebrity Update 7 August, 2025NationalWorld Celebrity Update 7 August, 2025 ...
The National Prosecuting Authority has provisionally withdrawn the charges against accused number two in the Limpopo pig farm ...
Anika Therapeutics is an HA-platform company with regenerative, OA pain, and non-orthopedic products. Read why ANIK stock ...
Eli Lilly’s potential obesity pill helped patients lose less weight than investors had hoped during a trial, sending shares in the drugmaker down as much as 12 per cent in pre-market trading.
While the injections from Lilly and Novo have revolutionized the way obesity is treated, investors say pills are key to ...
Adrian de Wet was one of three men facing murder charges after Maria Makgato, 45, and Lucia Ndlovu, 34, were killed while ...
Eli Lilly (LLY) stock plunges as Phase 3 trial data for the company's oral weight loss drug orforglipron overshadow better ...
Eli Lilly reported second quarter earnings Thursday, a day after competitor Novo Nordisk missed earnings estimates by Wall ...
In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that it helped people lower their weight by an average of 12% after 72 weeks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results